Nina Wettschureck and Stefan Offermanns - Physiological Reviews

More documents

Recommendations

Info

1198 NINA WETTSCHURECK AND STEFAN OFFERMANNS 493. Offermanns S, Mancino V, Revel JP, and Simon MI. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275: 533–536, 1997. 494. Offermanns S, Toombs CF, Hu YH, and Simon MI. Defective platelet activation in G alpha(q)-deficient mice. Nature 389: 183– 186, 1997. 495. Offermanns S, Zhao LP, Gohla A, Sarosi I, Simon MI, and Wilkie TM. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J 17: 4304– 4312, 1998. 496. Ohki-Hamazaki H. Neuromedin B. Prog Neurobiol 62: 297–312, 2000. 497. Ohman L, Franzen L, Rudolph U, Birnbaumer L, and Hornquist EH. Regression of Peyer’s patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis. Gut 51: 392–397, 2002. 498. Ohman L, Franzen L, Rudolph U, Harriman GR, and Hultgren Hornquist E. Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice. Scand J Immunol 52: 80–90, 2000. 499. Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, and Penninger JM. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 97: 12272–12277, 2000. 500. Olson TS and Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283: R7–R28, 2002. 501. Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, and Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol Pharmacol 65: 623–629, 2004. 502. O’Sullivan C, Barton CM, Staddon SL, Brown CL, and Lemoine NR. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4: 345–349, 1991. 503. Ozeki H, Kurihara Y, Tonami K, Watatani S, and Kurihara H. Endothelin-1 regulates the dorsoventral branchial arch patterning in mice. Mech Dev 121: 387–395, 2004. 504. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739–745, 2000. 505. Panda S, Nayak SK, Campo B, Walker JR, Hogenesch JB, and Jegla T. Illumination of the melanopsin signaling pathway. Science 307: 600–604, 2005. 506. Park JG, Bose A, Leszyk J, and Czech MP. PYK2 as a mediator of endothelin-1/G alpha 11 signaling to GLUT4 glucose transporters. J Biol Chem 276: 47751–47754, 2001. 507. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, and Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649–651, 1993. 508. Paschke R and Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med 337: 1675–1681, 1997. 509. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, and Huttner WB. Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J Biol Chem 275: 33622–33632, 2000. 510. Patel TB. Single transmembrane spanning heterotrimeric G protein-coupled receptors and their signaling cascades. Pharmacol Rev 56: 371–385, 2004. 511. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 20: 157–198, 1999. 512. Penn RB, Pascual RM, Kim YM, Mundell SJ, Krymskaya VP, Panettieri RA Jr, and Benovic JL. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem 276: 32648–32656, 2001. 513. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, and Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 74: 1445–1463, 2004. 514. Persaud SJ, Jones PM, and Howell SL. Effects of Bordetella pertussis toxin on catecholamine inhibition of insulin release from Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org intact and electrically permeabilized rat islets. Biochem J 258: 669–675, 1989. 515. Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, Beechey CV, Williamson CM, and Kelsey G. A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA 96: 3830–3835, 1999. 516. Petitcolin MA, Spitzbarth-Regrigny E, Bueb JL, Capdeville- Atkinson C, and Tschirhart E. Role of G(i)-proteins in norepinephrine-mediated vasoconstriction in rat tail artery smooth muscle. Biochem Pharmacol 61: 1169–1175, 2001. 517. Petitcolin MA, Vandeputte C, Spitzbarth-Regrigny E, Bueb JL, Capdeville-Atkinson C, and Tschirhart E. Lack of involvement of pertussis toxin-sensitive G proteins in norepinephrineinduced vasoconstriction of rat aorta smooth muscle. Biochem Pharmacol 61: 485–491, 2001. 518. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, and Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17: 3045–3051, 1998. 519. Pierce KL, Premont RT, and Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3: 639–650, 2002. 520. Pietruck F, Moritz A, Montemurro M, Sell A, Busch S, Rosskopf D, Virchow S, Esche H, Brockmeyer N, Jakobs KH, and Siffert W. Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated. Circ Res 79: 974–983, 1996. 521. Piiper A, Stryjek-Kaminska D, Klengel R, and Zeuzem S. CCK, carbachol, and bombesin activate distinct PLC-beta isoenzymes via Gq/11 in rat pancreatic acinar membranes. Am J Physiol Gastrointest Liver Physiol 272: G135–G140, 1997. 522. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, and Kelsey G. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat Genet 36: 818–826, 2004. 523. Plonk SG, Park SK, and Exton JH. The alpha-subunit of the heterotrimeric G protein G13 activates a phospholipase D isozyme by a pathway requiring Rho family GTPases. J Biol Chem 273: 4823–4826, 1998. 524. Ponce A, Bueno E, Kentros C, Vega-Saenz de Miera E, Chow A, Hillman D, Chen S, Zhu L, Wu MB, Wu X, Rudy B, and Thornhill WB. G protein-gated inward rectifier K � channel proteins (GIRK1) are present in the soma and dendrites as well as in nerve terminals of specific neurons in the brain. J Neurosci 16: 1990–2001, 1996. 525. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, and Foord SM. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233–246, 2002. 526. Preininger AM and Hamm HE. G protein signaling: insights from new structures. Sci STKE 2004: re3, 2004. 527. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, and Corkey BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267: 5802–5810, 1992. 528. Prescott SM, Zimmerman GA, Stafforini DM, and McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419–445, 2000. 529. Pulcinelli FM, Pesciotti M, Pignatelli P, Riondino S, and Gazzaniga PP. Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. FEBS Lett 435: 115–118, 1998. 530. Qiu X, Kumbalasiri T, Carlson SM, Wong KY, Krishna V, Provencio I, and Berson DM. Induction of photosensitivity by heterologous expression of melanopsin. Nature 433: 745–749, 2005. 531. Radecki SV, Deaver DR, and Scanes CG. Triiodothyronine reduces growth hormone secretion and pituitary growth hormone mRNA in the chicken, in vivo and in vitro. Proc Soc Exp Biol Med 205: 340–346, 1994. 532. Radhika V, Onesime D, Ha JH, and Dhanasekaran N. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 279: 49406–49413, 2004.
533. Radu CG, Yang LV, Riedinger M, Au M, and Witte ON. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci USA 101: 245–250, 2004. 534. Rana BK and Insel PA. G protein-coupled receptor websites. Trends Pharmacol Sci 23: 535–536, 2002. 535. Rapacciuolo A, Esposito G, Prasad SV, and Rockman HA. G protein-coupled receptor signalling in in vivo cardiac overload. Acta Physiol Scand 173: 51–57, 2001. 536. Rasolonjanahary R, Gerard C, Dufour MN, Homburger V, Enjalbert A, and Guillon G. Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Endocrinology 143: 747–754, 2002. 537. Renstrom E, Eliasson L, Bokvist K, and Rorsman P. Cooling inhibits exocytosis in single mouse pancreatic B-cells by suppression of granule mobilization. J Physiol 494: 41–52, 1996. 538. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70: 281–312, 2001. 539. Richardson SB, Laya T, and VanOoy M. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors. J Endocrinol 147: 59–65, 1995. 540. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, and Horwitz AR. Cell migration: integrating signals from front to back. Science 302: 1704–1709, 2003. 541. Riminucci M, Collins MT, Lala R, Corsi A, Matarazzo P, Gehron Robey P, and Bianco P. An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma. Mol Pathol 55: 58–60, 2002. 542. Robertson RP, Seaquist ER, and Walseth TF. G proteins and modulation of insulin secretion. Diabetes 40: 1–6, 1991. 543. Robishaw JD. Specificity of G protein betagamma dimer signaling. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic, 2004, p. 623–629. 544. Rockman HA, Hamilton RA, Jones LR, Milano CA, Mao L, and Lefkowitz RJ. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest 97: 1618– 1623, 1996. 545. Rockman HA, Koch WJ, and Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 415: 206–212, 2002. 546. Rodesch F, Neve P, Willems C, and Dumont JE. Stimulation of thyroid metabolism by thyrotropin, cyclic 3�:5�-AMP, dibutyryl cyclic 3�:5�-AMP and prostaglandin E1. Eur J Biochem 8: 26–32, 1969. 547. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, Kelly DP, and Muslin AJ. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest 104: 567–576, 1999. 548. Ronnett GV and Moon C. G proteins and olfactory signal transduction. Annu Rev Physiol 64: 189–222, 2002. 549. Rosenfeldt H, Marinissen MJ, and Gutkind JS. G proteincoupled receptors, cell transformation, and signal fidelity. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic, 2003, p. 589–599. 550. Ross EM and Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69: 795–827, 2000. 551. Rozengurt E. Early signals in the mitogenic response. Science 234: 161–166, 1986. 552. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, and Birnbaumer L. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 10: 143–150, 1995. 553. Ruest LB, Xiang X, Lim KC, Levi G, and Clouthier DE. Endothelin-A receptor-dependent and -independent signaling pathways in establishing mandibular identity. Development 131: 4413–4423, 2004. 554. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 8: 1227–1234, 2002. 555. Ruiz CJ, Wray K, Delay E, Margolskee RF, and Kinnamon SC. Behavioral evidence for a role of alpha-gustducin in glutamate taste. Chem Senses 28: 573–579, 2003. CELLULAR FUNCTIONS OF G PROTEINS 1199 Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org 556. Ruiz-Avila L, Wong GT, Damak S, and Margolskee RF. Dominant loss of responsiveness to sweet and bitter compounds caused by a single mutation in alpha-gustducin. Proc Natl Acad Sci USA 98: 8868–8873, 2001. 557. Ruiz-Velasco V and Ikeda SR. Multiple G protein betagamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons. J Neurosci 20: 2183–2191, 2000. 558. Rutter GA. Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med 22: 247–284, 2001. 559. Sabri A, Wilson BA, and Steinberg SF. Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res 90: 850–857, 2002. 560. Sadoshima J and Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413–423, 1993. 561. Sadoshima J, Qiu Z, Morgan JP, and Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2�)-dependent signaling. Circ Res 76: 1–15, 1995. 562. Sah VP, Hoshijima M, Chien KR, and Brown JH. Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 271: 31185–31190, 1996. 563. Sah VP, Seasholtz TM, Sagi SA, and Brown JH. The role of Rho in G protein-coupled receptor signal transduction. Annu Rev Pharmacol Toxicol 40: 459–489, 2000. 564. Sahai E and Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2: 133–142, 2002. 565. Sakmar TP, Menon ST, Marin EP, and Awad ES. Rhodopsin: insights from recent structural studies. Annu Rev Biophys Biomol Struct 31: 443–484, 2002. 566. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, and Penninger JM. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040–1046, 2000. 567. Satoh S, Ueda Y, Koyanagi M, Kadokami T, Sugano M, Yoshikawa Y, and Makino N. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. J Mol Cell Cardiol 35: 59–70, 2003. 568. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, and Herbert JM. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 422: 291–295, 1998. 569. Savi P, Pflieger AM, and Herbert JM. cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coagul Fibrinolysis 7: 249–252, 1996. 570. Schoenwaelder SM, Hughan SC, Boniface K, Fernando S, Holdsworth M, Thompson PE, Salem HH, and Jackson SP. RhoA sustains integrin alpha IIbbeta 3 adhesion contacts under high shear. J Biol Chem 277: 14738–14746, 2002. 571. Scholich K, Mullenix JB, Wittpoth C, Poppleton HM, Pierre SC, Lindorfer MA, Garrison JC, and Patel TB. Facilitation of signal onset and termination by adenylyl cyclase. Science 283: 1328–1331, 1999. 572. Schweda F and Kurtz A. Cellular mechanism of renin release. Acta Physiol Scand 181: 383–390, 2004. 573. Schwindinger WF, Betz KS, Giger KE, Sabol A, Bronson SK, and Robishaw JD. Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. J Biol Chem 278: 6575–6579, 2003. 574. Schwindinger WF, Francomano CA, and Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89: 5152–5156, 1992. 575. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB,
Page 1 and 2: Mammalian G Proteins and Their Cell
Page 3 and 4: TABLE 1. Physiological ligands of G
Page 5 and 6: TABLE 1—Continued Sensory Stimuli
Page 7 and 8: FIG. 1. Functional cycle of G prote
Page 9 and 10: promoter driving the expression of
Page 11 and 12: FIG. 5.G q/G 11 family G proteins a
Page 13 and 14: G proteins, which mediate bronchoco
Page 15 and 16: lets under physiological and pathol
Page 17 and 18: to mediate these effects. The forme
Page 19 and 20: e attributed to an impaired lipolyt
Page 21 and 22: kocytes (56). Indirect evidence for
Page 23 and 24: A. Visual System The human retina c
Page 25 and 26: addressed the role of G proteins in
Page 27 and 28: C. G i-Mediated Cell Transformation
Page 29 and 30: 45. Berstein G, Blank JL, Jhon DY,
Page 31 and 32: 123. Cyster JG. Chemokines, sphingo
Page 33 and 34: 207. Gehrmann J, Meister M, Maguire
Page 35 and 36: 290. Imamura T, Vollenweider P, Ega
Page 37 and 38: 369. Laurent E, Mockel J, Van Sande
Page 39: Local calcium release in dendritic
Page 43 and 44: 616. Suwazono Y, Okubo Y, Kobayashi
Page 45 and 46: 695. Wu D, Huang CK, and Jiang H. R

Nina Wettschureck and Stefan Offermanns - Physiological Reviews

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?